PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR — Salmeterol Importer Profile
Pharmaceutical Importer · #1 buyer for Salmeterol · $3.1M import value · 66 shipments · TURKEY · DGFT Verified
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR is the #1 importer of Salmeterol from India with $3.1M in import value and 66 verified shipments. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR holds a 4.5% market share in Salmeterol imports based in TURKEY. The company sources from 2 verified suppliers across 32 formulations shipped to 1 country. Overall, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports 5 pharmaceutical products worth $11.8M across 2 therapeutic categories.
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR — Salmeterol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Salmeterol to PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR?
Verified from 66 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $2.1M | 44 | 65.3% |
| MEDISPRAY LABORATORIES PRIVATE LIMITED | $1.1M | 22 | 34.7% |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR sources Salmeterol from 2 verified Indian suppliers based on 66 customs records. The primary supplier is CIPLA LIMITED accounting for 65.3% of imports.
How Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Compare to Nearest Salmeterol Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | CIPLA MAROC | MOROCCO | $4.4M | 88 | $50.0K |
| 1 | PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ★ | TURKEY | $3.3M | 66 | $50.0K |
| 7 | BREATHEFREE LANKA PVT LTD | SRI LANKA | $2.1M | 64 | $32.1K |
| 8 | LABORATORIOS RECALCINE SA.. | CHILE | $2.0M | 64 | $31.5K |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ranks #1 among 370 Salmeterol importers from India. Average shipment value of $50.0K compared to the market average of $61.5K. The closest competitors by value are CIPLA MAROC and BREATHEFREE LANKA PVT LTD.
Where Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import Salmeterol To?
Destination countries from 66 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $3.1M | 66 | 100.0% |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports Salmeterol to 1 country. The primary destination is TURKEY receiving 100.0% of shipments worth $3.1M.
What Salmeterol Formulations Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import?
| Formulation | Value | Shipments |
|---|---|---|
| SEROFLO 250 HFA INHALER (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 250MCG ) (1 X 120 MD) | $753.5K | 17 |
| SEROFLO 250 HFA INHALER SALMETEROL XINA | $500.0K | 10 |
| SEROFLO 125 HFA INHALER (WITH DOSE INDICATOR) (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 125MCG ) (1 X 120 MD) | $317.5K | 7 |
| FLUTICORT PLUS -250 HFA INHALER WITH DOSE INDICATOR 120 MD (SALMETEROL XINAFOATE 25 MCG + FLUTICASONE PROPIONATE 250 M | $150.0K | 3 |
| SEROFLO 250 HFA SYNCHROBREATHE SB (SALMETEROL XINAFOATE 25MCG+FLUTICASONE PROPIONATE 250MCG) | $100.0K | 2 |
| SEROFLO 250 HFA INHALER SALMETEROL XINAFOATE 25MCG FLUTICASONE PROPIONATE 250MCG 17926 PACK 1X120MD | $50.0K | 1 |
| SEROFLO 250 HFA INHALER SALMETEROL XINAFOATE 25MCG FLUTICASONE PROPIONATE 250MCG 17895 PACK 1X120MD | $50.0K | 1 |
| SEROFLO 250 HFA INHALER SALMETEROL XINAFOATE 25MCG FLUTICASONE PROPIONATE 250MCG 17766 PACK 1X120MD | $50.0K | 1 |
| SEROFLO 250 HFA INHALER SALMETEROL XINAFOATE 25MCG FLUTICASONE PROPIONATE 250MCG 17679 PACK 1X120MD | $50.0K | 1 |
| SEROFLO 250 HFA INHALER SALMETEROL XINAFOATE 25MCG FLUTICASONE PROPIONATE 250MCG 17598 PACK 1X120MD | $50.0K | 1 |
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports 32 distinct Salmeterol formulations from India. The top formulation is SEROFLO 250 HFA INHALER (SALMETEROL XINAFOATE 25MCG+FLUTICAS with 17 shipments worth $753.5K.
Who Are the Top Buyers of Salmeterol from India and How Much Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import?
India exported $22.8M worth of Salmeterol through 7,006 shipments from 148 suppliers to 90 countries, serving 370 buyers globally. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports $3.1M of this total, accounting for 4.5% of India's Salmeterol exports with 66 shipments from TURKEY. This is verified from 66 customs shipment records covering 32 distinct formulations.
What Is the Average Order Value for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's Salmeterol Imports?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's average Salmeterol order value is $47.6K per consignment, based on 66 shipments totaling $3.1M. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR is based in TURKEY and ranks #1 among all Salmeterol importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Salmeterol to PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR sources Salmeterol from 2 verified Indian suppliers: CIPLA LIMITED ($2.1M, 65.3%), MEDISPRAY LABORATORIES PRIVATE LIMITED ($1.1M, 34.7%). This is based on 66 customs records.
How Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Compare to Other Salmeterol Importers?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ranks #1 among 370 Salmeterol importers from India with a 4.5% market share. The top 3 importers are CIPLA MAROC ($4.4M), PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ($3.3M), BREATHEFREE LANKA PVT LTD ($2.1M). PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR processed 66 shipments from TURKEY.
What Other Respiratory Products Does PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR Import?
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR also imports these respiratory products. Each links to the detailed product page.
About PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR imports 5 products worth $11.8M. Beyond Salmeterol, top products include Fluticasone, Salbutamol, Methotrexate, Tiotropium. View the complete PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salmeterol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salmeterol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's capped import value divided by total capped export value for Salmeterol across all Indian exporters.
- 5.Verified Records: This page is backed by 66 individual customs records matching PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR importing Salmeterol, covering 32 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 90+ countries, 370+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salmeterol Import Data for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
Access order-level details, pricing data, supplier connections, and competitive analysis for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR's Salmeterol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
Full Company Profile →
5 products · $11.8M total trade · 2 categories
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR × Salmeterol
Verified from customs records
Company Overview
Top Products by PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salmeterol. For current order-level data, contact TransData Nexus.